seed
Stage
2
Investors
About
Neobe Therapeutics develops engineered live biotherapeutics using synthetic biology to target and disrupt the microenvironment of solid tumors, enhancing the effectiveness of immunotherapy in cancer patients.
Explore Neobe Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.